Navigation Links
MedCath Names Parker to New Finance Post
Date:5/12/2008

CHARLOTTE, N.C., May 12 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH), a health care provider focused on high acuity health care services, predominantly the diagnosis and treatment of cardiovascular disease, today announced that Art Parker, Senior Vice-President and Treasurer and currently Interim Chief Financial Officer, has been named Senior Vice-President, Finance and Development effective immediately.

"In his new role, Art will continue to oversee and direct Treasury and other Finance activities but will also be engaged in the acquisition and transactional pipeline, due diligence and other development matters," according to O. Edwin French, MedCath's President and Chief Executive Officer. "Art has distinguished himself as a capable and engaged executive who has earned the confidence of our partners and bankers, and who has proven himself in several transactions during his time with MedCath. We are developing our bench strength to match our growth ambitions, and Art will be important to that process."

Prior to joining MedCath in 2001, Parker worked for Bank of America for 14 years, holding posts related to the management of commercial banking relationships, the development of credit underwriting standards and approvals, and serving as a fixed income bond analyst covering the health care and other industries.

He holds a bachelor's degree in business administration from the University of Georgia and an MBA from Wake Forest University, Winston-Salem, N.C.

MedCath is nearing a completion of its search for a chief financial officer to fill the post vacated in January. An announcement is expected within the next several weeks.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. Following completion of the divestiture of Dayton Heart Hospital, MedCath will own an interest in and operate nine hospitals with a total of 616 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota and Texas. In addition, MedCath and its subsidiary MedCath Partners manage the cardiovascular program at various hospitals and provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
2. MedCath Corporation Reports Second Quarter Earnings
3. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
4. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
5. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
6. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
7. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
8. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
11. MedCath Announces Venture With Two New Jersey Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: